Serum free light chain immunoassays and their clinical application
- 1 November 2002
- journal article
- Published by Elsevier in Clinical and Applied Immunology Reviews
- Vol. 3 (1-2) , 17-33
- https://doi.org/10.1016/s1529-1049(02)00064-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Differences in kappa to lambda (κ:λ) ratios of serum and urinary free light chainsClinical and Experimental Immunology, 1998
- Risk of disease progression in asymptomatic multiple myelomaThe American Journal of Medicine, 1993
- Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myelomaBritish Journal of Haematology, 1992
- Immunoturbidimetric assay for estimating free light chains of immunoglobulins in urine and serum.Journal of Clinical Pathology, 1991
- Clinical relapse in systemic lupus erythematosus: Correlation with antecedent elevation of urinary free light-chain immunoglobulinJournal of Clinical Immunology, 1989
- Free light chains in multiple sclerosis and infections of the CNSNeurology, 1987
- Quantitation of free κ light chains in serum and urine using a monoclonal antibody based inhibition enzyme-linked immunoassayJournal of Immunological Methods, 1987
- Estimation of free light chains of immunoglobulins by enzyme immunoassayClinica Chimica Acta; International Journal of Clinical Chemistry, 1985
- Free Light Chains of Immunoglobulins in Serum from Patients with Rheumatoid Arthritis, Sarcoidosis, Chronic Infections and Pulmonary CancerActa Medica Scandinavica, 1981
- The renal handling of low molecular weight proteinsJournal of Clinical Investigation, 1972